Understanding beta-cell destruction through the study of EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum study)

Research summary

A study to assess clinical phenotype, beta cell function, genetics, and autoantibodies in Extremely Early Type 1 Diabetes (EET1D) to better understand the aetiology and progression of beta cell destruction in Type 1 diabetes (T1D) occurring in the first year of life. As a study of a very rare disease ( < 100 in UK) defined by genetics, it is adopted as a Musketeers' Memorandum Study.

Principal Investigator

Dr Rachel Besser

Contact us

Email: childrensresearch@ouh.nhs.uk

IRAS number

228082